Updated on: October 16, 2026
Written and source checked by: Adel Galal, Founder and Lead Writer at NextFitLife
Medical review status: This article has not been medically reviewed by a doctor, endocrinologist, rheumatologist, pharmacist, registered dietitian, physical therapist, or other licensed healthcare professional.
Osteoporosis treatment aims to prevent fractures, preserve bone strength, and keep you active. For some people, lifestyle care is enough to support bone health. Once fracture risk is high, though, prescription medicine often becomes an important part of treatment.
The best plan depends on more than a DXA score. Age, previous fractures, how recent those fractures were, steroid use, kidney function, fall risk, other illnesses, and the medicine you have already used all matter.
This article is for general information and education. It does not replace medical advice, diagnosis, or treatment.
For a wider overview of bone loss, fracture risk, DXA scans, and prevention, visit the NextFitLife Bone and Joint Health Hub.
Table of Contents
- What osteoporosis treatment is trying to achieve
- Who needs medicine
- 11 proven treatment steps
- Measure fracture risk
- Correct calcium and vitamin D gaps
- Use bisphosphonates when appropriate
- Understand denosumab
- Use bone building treatment for very high risk
- Plan the treatment sequence
- Strengthen muscle and bone
- Reduce falls
- Treat secondary causes
- Monitor treatment
- Review long term therapy
- Medicine comparison
- Side effects and dental care
- DXA follow up
- Diet, supplements, and exercise
- Frequently asked questions
What Is Osteoporosis Treatment Trying to Achieve?
The goal is simple: prevent fractures.
Increasing bone density is useful, but the real outcome that matters is whether treatment lowers the chance of breaking a hip, spine, wrist, or another bone.
A good plan can include:
- Bone density monitoring
- Calcium and vitamin D assessment
- Resistance and weight bearing exercise
- Balance training
- Fall prevention
- Treatment of medical causes of bone loss
- Prescription osteoporosis medicine
The mix depends on the person's risk.
Who Actually Needs Osteoporosis Medicine?
Not every person with low bone density needs the same treatment.
Medicine is more likely to be recommended when there is:
- A previous hip or vertebral fracture
- A fragility fracture
- A DXA result in the osteoporosis range
- High calculated fracture risk
- Long term glucocorticoid use
- Very low bone density
- Multiple major risk factors
Someone with a recent vertebral fracture or several fractures can fall into a very high fracture risk group.
That matters because treatment order can change.
1. Start With Fracture Risk, Not Just the T Score
A DXA result is useful, but it is not the whole diagnosis.
Doctors also look at:
- Age
- Previous fractures
- How recent the fracture was
- Number of fractures
- Glucocorticoid use
- Smoking
- Alcohol use
- Falls
- Body weight
- Family history
- Medical conditions
A person who fractured a vertebra recently can need stronger treatment than another person with the same T score and no previous fracture.
This is why fracture history should never be buried under the scan result.
2. Correct Calcium and Vitamin D Gaps
Calcium and vitamin D support osteoporosis treatment, but they are not substitutes for fracture lowering medicine when that medicine is needed.
Adults commonly need around 1,000 to 1,200 mg of calcium per day depending on age and sex.
Useful calcium foods include:
- Milk
- Yogurt
- Cheese
- Calcium fortified plant drinks
- Calcium set tofu
- Sardines with edible bones
- Canned salmon with bones
- Kale
- Bok choy
Vitamin D supports calcium absorption and muscle function.
For adults without a special medical indication, NIH recommendations include 600 IU daily through age 70 and 800 IU from age 71 onward.
People with deficiency or some medical conditions can need a different treatment plan.
Read more in the Bone and Joint Nutrition Hub.
3. Bisphosphonates Are a Common First Treatment
Bisphosphonates slow bone breakdown.
Common options include:
- Alendronate
- Risedronate
- Zoledronic acid
- Ibandronate in selected situations
For many people at high fracture risk, oral alendronate or risedronate, or intravenous zoledronic acid, are common first choices.
Why are they used so often?
They have strong evidence for fracture prevention, long clinical experience, and relatively low cost.
Some forms are taken by mouth, while zoledronic acid is given through a vein.
Who may struggle with oral bisphosphonates?
People with significant swallowing problems, some esophageal disorders, difficulty following the dosing instructions, or poor tolerance may need a different option.
Kidney function also matters when choosing treatment.
4. Denosumab Works Well, but It Needs a Long Term Plan
Denosumab is an antiresorptive medicine given by injection.
It can be effective for people at high fracture risk and is an alternative first treatment in appropriate patients.
The important part is what happens later.
Denosumab is not a medicine that should be stopped casually.
Its effect on bone turnover wears off when doses are missed or treatment stops. Bone loss can return quickly, and multiple vertebral fractures have been reported after unplanned discontinuation.
A treatment exit plan should ideally be discussed before the first injection rather than after the final one.
5. Very High Fracture Risk Can Call for Bone Building Treatment First
This is one of the biggest changes in modern osteoporosis care.
Some people are not merely “high risk.” They are very high risk.
Examples can include:
- A recent vertebral fracture
- Multiple vertebral fractures
- Very low bone density
- Fracture while on treatment
- Several major fracture risk factors together
- High dose long term glucocorticoid exposure
In these patients, doctors may consider a bone building treatment before starting or returning to an antiresorptive medicine.
Teriparatide
Teriparatide stimulates new bone formation.
It is used for selected people with very high fracture risk.
Abaloparatide
Abaloparatide is another bone building treatment used in selected patients.
Romosozumab
Romosozumab increases bone formation and reduces bone breakdown.
Its treatment course is limited, and cardiovascular history matters when deciding whether it is appropriate.
6. Treatment Sequence Matters
This is where many lighter osteoporosis articles stop too early.
Bone building medicines are usually not the end of treatment.
After completing teriparatide, abaloparatide, or romosozumab, an antiresorptive medicine is normally started without a long gap.
Why?
The new bone density gains need to be preserved.
The same principle explains why denosumab requires a planned follow on strategy when it is stopped.
7. Resistance Exercise Should Be Part of Treatment
Medicine treats fracture risk.
Exercise helps with bone loading, muscle, balance, and independence.
Resistance exercise can include:
- Free weights
- Resistance bands
- Weight machines
- Body weight exercises
- Chair squats
- Step exercises
Weight bearing exercise can include walking, stairs, hiking, and dancing.
If you have vertebral fractures, severe osteoporosis, major balance problems, or pain, exercise should be adapted by a clinician or physical therapist who understands osteoporosis.
For general activity guidance, read Benefits of Physical Activity.
8. Fall Prevention Can Prevent the Fracture Before It Happens
A strong treatment plan does not focus only on bone density.
Falls cause many fractures.
Practical steps include:
- Improve lighting
- Remove loose rugs
- Keep stairs clear
- Use handrails
- Use nonslip bathroom surfaces
- Check vision
- Review medicines that cause dizziness
- Improve leg strength
- Train balance
If you feel unsteady, tell your clinician rather than simply trying to “be more careful.”
For an age specific exercise guide, see Walking Exercise for Seniors.
9. Look for Secondary Causes of Osteoporosis
Sometimes osteoporosis is not simply the result of aging.
Bone loss can be made worse by:
- Long term glucocorticoids
- Celiac disease
- Some thyroid disorders
- Parathyroid disease
- Low sex hormone levels
- Chronic kidney disease
- Some liver diseases
- Malabsorption
- Some cancers
- Some cancer treatments
If bone density is unexpectedly low or fractures occur despite treatment, looking for a secondary cause matters.
Simply increasing calcium can miss the real problem.
10. Monitor Treatment, but Do Not Scan on a Fixed Schedule for Everyone
DXA follow up should be individualized.
There is no universal rule that every person needs a bone density scan every year or every two years.
Monitoring depends on:
- Initial fracture risk
- Treatment being used
- Previous fractures
- Expected rate of bone change
- Whether treatment adherence is uncertain
- Whether another fracture has occurred
Some high risk patients are monitored more closely.
The same DXA machine and site are useful for comparison when possible.
11. Long Term Treatment Needs Planned Reassessment
Osteoporosis is a long term condition.
That does not mean every medicine continues forever in exactly the same way.
Bisphosphonates
Fracture risk is usually reassessed after a period of treatment.
Some lower risk patients can have a temporary treatment pause after enough bisphosphonate exposure.
Higher risk patients may need to continue.
Denosumab
A treatment holiday is not handled the same way.
Denosumab should not simply be paused because its protective effect does not remain in bone the way bisphosphonate effects can.
This difference is easy to miss and clinically important.
Osteoporosis Medicines at a Glance
| Treatment | Main Role | Key Point |
|---|---|---|
| Alendronate | Antiresorptive | Common oral first line option |
| Risedronate | Antiresorptive | Common oral treatment |
| Zoledronic acid | Antiresorptive | Intravenous option, useful when oral treatment does not fit |
| Denosumab | Antiresorptive | Do not stop without follow on treatment |
| Teriparatide | Bone building | Used for selected very high risk patients |
| Abaloparatide | Bone building | Follow with antiresorptive therapy |
| Romosozumab | Bone building plus antiresorptive effect | Limited course, cardiovascular risk must be reviewed |
| Raloxifene | Selective estrogen receptor modulator | Used in selected postmenopausal women |
What Are the Main Side Effects of Osteoporosis Medicines?
Every medicine has tradeoffs.
The decision should compare medicine risk with fracture risk.
Bisphosphonates
Oral forms can irritate the upper digestive tract in some people.
Rare complications with long term antiresorptive treatment include osteonecrosis of the jaw and atypical femur fracture.
These events are uncommon in osteoporosis treatment, but they are real and should be discussed in context.
Denosumab
Possible problems include low calcium levels, skin reactions, and rare osteonecrosis of the jaw or atypical femur fracture.
The major management issue is avoiding unplanned discontinuation.
Romosozumab
Cardiovascular history matters.
It may not be suitable for people at high cardiovascular risk or with a recent heart attack or stroke, depending on local prescribing guidance.
Do You Need Dental Work Before Treatment?
Good dental care matters, especially with antiresorptive medicines.
Tell your dentist which osteoporosis medicine you take.
Brush, floss, attend routine dental care, and report:
- Jaw pain
- Nonhealing mouth sores
- Exposed bone
- Loose teeth without a clear dental cause
Do not stop osteoporosis medicine before dental work without discussing it with the prescriber.
What Is a Bisphosphonate Holiday?
A bisphosphonate holiday is a planned temporary pause in treatment for selected people after enough therapy.
It is not appropriate for everyone.
People with high fracture risk may need to keep taking treatment.
The decision depends on fracture history, age, bone density, treatment duration, and other risk factors.
Can Osteoporosis Be Treated Without Medicine?
Sometimes lifestyle care is enough for a person whose fracture risk is not high.
Once osteoporosis or fracture risk reaches a treatment threshold, though, diet and exercise alone may not provide enough protection.
Lifestyle treatment still matters because it supports:
- Bone nutrition
- Muscle strength
- Balance
- Mobility
- Fall reduction
But it should work alongside medicine when medicine is indicated.
Can Osteoporosis Medicine Rebuild Bone?
Some treatments mainly slow bone breakdown.
Others stimulate bone formation.
That difference explains the two broad groups:
- Antiresorptive medicines reduce bone loss
- Anabolic medicines stimulate new bone formation
Romosozumab has effects on both bone formation and bone breakdown.
The goal is not merely to raise a scan number. It is to reduce future fracture risk.
How Fast Does Osteoporosis Treatment Work?
There is no useful rule that every treatment works in a set number of weeks.
Bone changes slowly.
Fracture protection, bone turnover changes, and DXA changes happen on different timelines depending on the treatment.
This is one reason adherence matters.
Do not stop medicine because you cannot “feel” stronger bones.
Osteoporosis treatment is usually working silently.
What If You Fracture While Taking Treatment?
A fracture during treatment does not automatically mean the medicine failed.
But it deserves review.
Your clinician may check:
- Whether doses were taken correctly
- Whether treatment has been taken long enough
- Whether another condition is causing bone loss
- Whether fracture risk is now very high
- Whether a different treatment sequence would be better
This is one situation where moving to a bone building medicine may be considered in selected patients.
What Should You Eat During Osteoporosis Treatment?
Build meals around enough total food, protein, calcium, and vitamin D.
Useful foods include:
- Milk and yogurt
- Fortified plant drinks
- Fish
- Eggs
- Beans
- Lentils
- Tofu
- Leafy vegetables
- Nuts and seeds
- Fruit and vegetables
Avoid assuming that one “bone superfood” can replace the rest of treatment.
For detailed food guidance, see Bone and Joint Nutrition.
Do Vitamin K2 and Magnesium Treat Osteoporosis?
Vitamin K and magnesium have normal roles in the body.
That does not make supplements substitutes for proven osteoporosis medicine.
Claims that K2 simply sends calcium into bone and away from arteries oversimplify human biology.
If your fracture risk is high, do not delay appropriate treatment while trying supplement combinations.
For a broader supplement guide, read Vitamins for Strong Bones and Joints.
When Should Treatment Be Reviewed?
Review is especially important when:
- You have a new fracture
- Your bone density falls significantly
- You develop side effects
- You cannot take the medicine correctly
- Your kidney function changes
- You start long term steroids
- You are approaching the planned end of a treatment course
- You are considering stopping denosumab
A review should ask two questions:
Is fracture risk still high?
Is this still the right medicine and treatment sequence?
Common Osteoporosis Treatment Mistakes
| Mistake | Why It Matters | Better Approach |
|---|---|---|
| Using calcium as the whole treatment | It does not provide enough fracture protection for many high risk patients | Treat the whole fracture risk picture |
| Stopping denosumab without a plan | Rapid bone loss and vertebral fractures can follow | Plan follow on antiresorptive treatment |
| Assuming every person needs the same medicine | Risk levels and medical histories differ | Match treatment to fracture risk |
| Ignoring falls | A fall can trigger a fracture even during treatment | Add balance and home safety |
| Scanning on a rigid schedule | Monitoring needs differ | Use individualized follow up |
| Stopping treatment because you feel well | Osteoporosis is usually silent | Review treatment with your clinician first |
Conclusion: Treat the Fracture Risk, Not Just the Scan
Osteoporosis treatment works best when it is matched to fracture risk rather than reduced to calcium tablets or one DXA number.
For many people, treatment starts with a bisphosphonate or another antiresorptive medicine. Very high risk patients may benefit from bone building treatment first, followed by antiresorptive therapy to protect the gain.
Your next step should be concrete. If you have osteoporosis, a fragility fracture, very low bone density, long term steroid use, or are thinking about stopping denosumab, ask your clinician to review your fracture risk and long term treatment sequence.
References and Sources
- National Osteoporosis Guideline Group. Pharmacological Treatment Options.
Covers bisphosphonates, denosumab, anabolic treatment, treatment sequence, denosumab discontinuation, and long term management.
https://www.nogg.org.uk/full-guideline/section-6-pharmacological-treatment-options - 2024 UK Clinical Guideline for the Prevention and Treatment of Osteoporosis.
Covers high and very high fracture risk, antiresorptive medicine, anabolic therapy, treatment order, monitoring, and long term review.
https://pmc.ncbi.nlm.nih.gov/articles/PMC12417299/ - Endocrine Society. Pharmacological Management of Osteoporosis in Postmenopausal Women.
Covers first line bisphosphonates, denosumab, anabolic treatment, treatment reassessment, and sequential therapy.
https://www.endocrine.org/clinical-practice-guidelines/osteoporosis-in-postmenopausal-women - Bone Health and Osteoporosis Foundation. Denosumab.
Provides patient focused information on denosumab indications, fracture risk, and treatment use.
https://www.bonehealthandosteoporosis.org/patients/treatment/medicationadherence/denosumab/ - Bone Health and Osteoporosis Foundation. Romosozumab.
Explains romosozumab use, dosing period, high risk indications, and the need for follow on antiresorptive therapy.
https://www.bonehealthandosteoporosis.org/romosozumab-aqqg-evenity/ - NIH Office of Dietary Supplements. Calcium Fact Sheet.
Covers calcium needs, foods, supplements, absorption, interactions, and upper intake limits.
https://ods.od.nih.gov/factsheets/Calcium-HealthProfessional/ - NIH Office of Dietary Supplements. Vitamin D Fact Sheet.
Covers vitamin D intake, food sources, bone health, deficiency, and safety.
https://ods.od.nih.gov/factsheets/VitaminD-Consumer/
Internal Links and Helpful NextFitLife Guides
- Osteoporosis: Causes, Risks, Screening, and Prevention
- How to Prevent Osteoporosis
- Bone and Joint Health Hub
- Bone and Joint Nutrition Hub
- Vitamins for Strong Bones and Joints
- Vitamin D Benefits
- Benefits of Physical Activity
- Walking Exercise for Seniors
About the Author
Adel Galal is the Founder and Lead Writer at NextFitLife. He researches bone health, nutrition, fitness, healthy aging, screening, and evidence based treatment guidance and turns current medical and public health information into clear practical content for everyday readers.
I am not a doctor or licensed healthcare professional, and this content does not replace professional medical advice, diagnosis, or treatment. I share information based on extensive research, real life experience, and consultation with healthcare providers. Always consult a qualified healthcare professional for diagnosis, treatment, or guidance about any health condition.
Learn more about Adel, NextFitLife, and the site's editorial approach on the About Us page.
Frequently Asked Questions
What is the best treatment for osteoporosis?
There is no single best medicine for everyone. Many high risk patients start with a bisphosphonate, while very high risk patients may need a bone building treatment first. The choice depends on fracture history, bone density, age, kidney function, and other medical factors.
Can osteoporosis be treated without medicine?
People at lower fracture risk may sometimes be managed with exercise, nutrition, and risk reduction alone. Once fracture risk is high enough, prescription medicine is often needed to lower fracture risk effectively.
What is the first line medicine for osteoporosis?
Oral alendronate or risedronate and intravenous zoledronic acid are common first line options for many people at high fracture risk. The correct choice depends on individual health and fracture risk.
What is the difference between antiresorptive and bone building medicine?
Antiresorptive medicines slow bone breakdown. Bone building medicines stimulate new bone formation. People at very high fracture risk may benefit from a bone building medicine followed by antiresorptive treatment.
Why should denosumab not be stopped suddenly?
When denosumab is stopped or delayed, bone turnover can rebound and bone density can fall quickly. This can increase vertebral fracture risk, so another antiresorptive treatment is usually planned before discontinuation.
Can I take a drug holiday from denosumab?
No routine denosumab holiday is recommended. Denosumab behaves differently from bisphosphonates and should not be stopped without a planned transition to another treatment.
What is a bisphosphonate holiday?
A bisphosphonate holiday is a planned temporary pause after enough treatment in selected lower risk patients. High risk patients may need to continue treatment instead.
Can osteoporosis medicine rebuild bone?
Bone building treatments such as teriparatide, abaloparatide, and romosozumab can increase bone formation. Antiresorptive medicines mainly reduce bone breakdown.
How often should a DXA scan be repeated during treatment?
There is no single schedule for everyone. Follow up depends on fracture risk, treatment type, previous fractures, bone density, and whether treatment response or adherence needs closer review.
Do calcium and vitamin D treat osteoporosis?
They support bone health and osteoporosis treatment, but they do not replace fracture lowering medicine when a person's risk is high enough to need prescription therapy.
Is exercise safe with osteoporosis?
Yes, and exercise is usually encouraged. Resistance, weight bearing, and balance exercise are useful, but people with vertebral fractures or severe osteoporosis may need a modified programme.
What happens if I fracture while taking osteoporosis medicine?
Your clinician should review adherence, treatment duration, secondary causes of bone loss, current fracture risk, and whether another treatment or treatment sequence would be more suitable.
Does everyone with osteoporosis need the same medicine?
No. Treatment depends on fracture history, how high the fracture risk is, kidney function, other illnesses, previous medicines, age, and patient preference.
How long does osteoporosis treatment last?
Treatment duration depends on the medicine and fracture risk. Bisphosphonate therapy is reassessed after several years, while some bone building medicines have fixed treatment periods. Denosumab needs continued treatment or a planned transition rather than a casual pause.
Health & wellness writer with 30+ years of experience in nutrition, fitness, and healthy aging. Founder of NextFitLife.com — evidence-based health guidance.
